Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Neurology"
DOI: 10.1007/s00415-019-09234-y
Abstract: ObjectivesInfliximab is increasingly used to treat neurosarcoidosis. We aimed to determine the efficacy and tolerance of an infliximab biosimilar for treating neurosarcoidosis.MethodsWe conducted a retrospective single-center study to describe the efficacy, safety and immunogenicity of… read more here.
Keywords: originator; treatment; efficacy; treating neurosarcoidosis ... See more keywords